These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15069678

  • 1. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
    Kitago M, Ueda M, Aiura K, Suzuki K, Hoshimoto S, Takahashi S, Mukai M, Kitajima M.
    Int J Cancer; 2004 Jun 10; 110(2):177-82. PubMed ID: 15069678
    [Abstract] [Full Text] [Related]

  • 2. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y.
    Cancer; 2001 Oct 01; 92(7):1807-17. PubMed ID: 11745253
    [Abstract] [Full Text] [Related]

  • 3. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, Fukayama M.
    Virchows Arch; 2002 Nov 01; 441(5):437-43. PubMed ID: 12447672
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
    Z'graggen K, Rivera JA, Compton CC, Pins M, Werner J, Fernández-del Castillo C, Rattner DW, Lewandrowski KB, Rustgi AK, Warshaw AL.
    Ann Surg; 1997 Oct 01; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K, Hiyama E, Murakami Y, Kanehiro T, Ohge H, Sueda T, Yokoyama T.
    Oncol Rep; 2003 Oct 01; 10(2):277-83. PubMed ID: 12579258
    [Abstract] [Full Text] [Related]

  • 6. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.
    Raimondo M, Tachibana I, Urrutia R, Burgart LJ, DiMagno EP.
    Am J Gastroenterol; 2002 Oct 01; 97(10):2553-8. PubMed ID: 12385438
    [Abstract] [Full Text] [Related]

  • 7. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, Hirakawa K.
    Int J Oncol; 2002 Nov 01; 21(5):1067-72. PubMed ID: 12370756
    [Abstract] [Full Text] [Related]

  • 8. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K.
    J Hepatobiliary Pancreat Surg; 2002 Nov 01; 9(1):76-85. PubMed ID: 12021900
    [Abstract] [Full Text] [Related]

  • 9. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G.
    Cancer; 1999 Apr 15; 85(8):1703-10. PubMed ID: 10223563
    [Abstract] [Full Text] [Related]

  • 10. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
    Sugio K, Gazdar AF, Albores-Saavedra J, Kokkinakis DM.
    Carcinogenesis; 1996 Feb 15; 17(2):303-9. PubMed ID: 8625455
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
    Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, Pellegata NS, Ranzani GN, Rickaert F, Klöppel G.
    Virchows Arch; 1994 Feb 15; 425(4):357-67. PubMed ID: 7820300
    [Abstract] [Full Text] [Related]

  • 15. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE, Finkelstein SD, Ohori NP.
    Diagn Cytopathol; 2006 Sep 15; 34(9):605-8. PubMed ID: 16900481
    [Abstract] [Full Text] [Related]

  • 16. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors.
    Kaino M, Kondoh S, Okita S, Hatano S, Shiraishi K, Kaino S, Okita K.
    Pancreas; 1999 Apr 15; 18(3):294-9. PubMed ID: 10206488
    [Abstract] [Full Text] [Related]

  • 17. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
    Komori T, Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, Nakaizumi A, Uehara H, Tanaka S, Mano Y, Kasugai T.
    Jpn J Clin Oncol; 2002 Apr 15; 32(4):146-51. PubMed ID: 12072425
    [Abstract] [Full Text] [Related]

  • 18. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.
    Kobayashi N, Inamori M, Fujita K, Fujisawa T, Fujisawa N, Takahashi H, Yoneda M, Abe Y, Kawamura H, Shimamura T, Kirikoshi H, Kubota K, Sakaguchi T, Saito S, Saubermann LJ, Nakajima A.
    J Hepatobiliary Pancreat Surg; 2008 Apr 15; 15(2):169-77. PubMed ID: 18392710
    [Abstract] [Full Text] [Related]

  • 19. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
    Jinfeng M, Kimura W, Sakurai F, Moriya T, Takeshita A, Hirai I.
    Int J Gastrointest Cancer; 2002 Apr 15; 32(2-3):73-81. PubMed ID: 12794243
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.